Koninklijke DSM NV
AEX:DSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (2.6), the stock would be worth €114.05 (0% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.6 | €114.05 |
0%
|
| 3-Year Average | 2.6 | €114.05 |
0%
|
| 5-Year Average | 2.6 | €114.05 |
0%
|
| Industry Average | 12.4 | €540.52 |
+374%
|
| Country Average | 16.4 | €711.77 |
+524%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| NL |
|
Koninklijke DSM NV
AEX:DSM
|
568.6m EUR | 2.6 | 0.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.5T JPY | 23.1 | 28.4 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
78.7B USD | 23.9 | 30.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
72.4B USD | 34.1 | 34.9 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | -68 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
282.8B CNY | 16.6 | 21.5 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.7B CHF | 32.6 | 23.9 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 59.7 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR | 48 | 60.7 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
23.4B USD | 12.3 | 14.8 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 20 | 17.5 |
Market Distribution
| Min | 1.8 |
| 30th Percentile | 11.7 |
| Median | 16.4 |
| 70th Percentile | 33.6 |
| Max | 11 481.8 |
Other Multiples
Koninklijke DSM NV
Glance View
Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 21,358 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
